This past April, a piece by R.A. Harrington and a team from Johns Hopkins Bloomberg School of Public Health published in Pediatrics titled “Prenatal SSRI Use and Offspring With Autism Spectrum Disorder or Developmental Delay.” further illustrates the
Dangerous Drugs & Medical Devices
News & Commentary on Prescription Drug & Medical Device Lawsuits
The blog published by Justinian Lane focuses on legal issues related to dangerous drugs and medical devices, with particular attention to asbestos and mesothelioma claims. It covers topics such as asbestos litigation, trust funds, sources of asbestos exposure, and related diseases. The blog also addresses legal challenges involving medical devices like inferior vena cava (IVC) filters, including their usage guidelines, complications, and FDA regulatory actions. Additionally, it discusses litigation against chemical companies for harmful products, FDA warnings to medical device manufacturers, and other product liability matters involving pharmaceuticals and medical devices.
Latest from Dangerous Drugs & Medical Devices - Page 6
Study finds some babies more likely to have SSRI birth defects than others
Last summer, Developmental Psychobiology published a piece by S. Brummelte and a team from University of British Columbia (Vancouver) titled “Antidepressant use during pregnancy and serotonin transporter genotype (SLC6A4) affect newborn serum reelin levels.” exploring contributing genetic factors…
2005 – Higher rate of birth defects with Depacon in pregnancy
A 2005 article in Acta Neurologica Scandinavica by F.J. Vajda and a team from University of Melbourne (Australia) titled “Maternal valproate dosage and foetal malformations.” further elucidates the connection between prenatal exposure to antiepileptic drugs like Depacon and…
Depacon Doubles Risk for Birth Defects (At Least)
Another article demonstrating that prenatal exposure to antiepileptic drugs containing valproate like Depacon is associated with birth defects, “Valproate and the risk for congenital malformations: Is formulation and dosage regime important?” was published in the April, 2012 edition…
2- to 3-fold increase in birth defects linked to Depacon / Depakote / Depakene
In 2005, a team of researchers from The University of Pavia (Pavia, Italy) published a study in Lancet Neurology titled “Birth defects after prenatal exposure to antiepileptic drugs.”, yet again demonstrating that in utero exposure to Depacon,…
2012 – Babies with Depakote exposure more likely to have malformations
Published in the January, 2012 edition of Journal of Clinical Neuroscience, an article by F.J. Vajda titled “Teratogenicity of the newer antiepileptic drugs–the Australian experience.” provides important insight into the connection between valproate-containing antiepileptic drugs such as Depacon…
Study links maternal SSRIs and childhood autism
A New England Journal of Medicine article published in December, 2013 by A. Hviid et al. titled “Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.” demonstrates further the connection between prenatal exposure to a…
Depakote raises risk for birth defects 2- to 4-fold
In recent years, dozens of studies have linked prenatal exposure to the antiepileptic drugs containing valproate (Depacon, Depakene, and Depakote) with birth defects including spina bifida, and developmental disorders such as Autism. Since the…
Huge increase in birth defect risk with prenatal Depacon, AED exposure
Titled “Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study.”, a study by K. Wide et al. (2004) further demonstrates knowledge in the medical community…
Offspring maladaptive with in utero SSRI epxosure
Today, looking through PubMed Health, a medical literature database curated by the United States National Library of Medicine and The National Institutes of Health, I found another article linking poor neonatal outcomes and to birth defects prenatal exposure…